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against the detrimental effects of acute ischemia-reperfusion injury (IRI). It describes an
endogenous phenomenon in which the application of one or more brief cycles of non-lethal
ischemia and reperfusion to an organ or tissue protects a remote organ or tissue from a
sustained episode of lethal IRI. Although RIC protection was ﬁrst demonstrated to protect
the heart against acute myocardial infarction, its beneﬁcial effects are also seen in other
organs (lung, liver, kidney, intestine, brain) and tissues (skeletal muscle) subjected to acute
IRI. The recent discovery that RIC can be induced non-invasively by simply inﬂating and
deﬂating a standard blood pressure cuff placed on the upper arm or leg, has facilitated its
translation into the clinical setting, where it has been reported to be beneﬁcial in a variety
of cardiac scenarios. In this review article we provide an overview of RIC, the potential
underlying mechanisms, and its potential as a novel therapeutic strategy for protecting the
heart and other organs from acute IRI.
Keywords: remote ischemic preconditioning, remote ischemic perconditioning, remote ischemic postconditioning,
ischemia-reperfusion injury
INTRODUCTION
Coronary heart disease (CHD) is the leading cause of morbidity
and mortality worldwide (Lloyd-Jones et al., 2009). Despite opti-
mal therapy, patients with CHD still suffer signiﬁcant morbidity
and mortality. As such, novel therapeutic strategies for protect-
ing the heart against the detrimental effects of acute ischemia-
reperfusion injury (IRI), the major pathological consequence of
CHD, are required to improve clinical outcomes in patients with
CHD.
In this regard, the phenomenon of ischemic conditioning may
provide an endogenous strategy for protecting the heart against
acute IRI. Murry et al. (1986) ﬁrst described the phenomenon
of ischemic preconditioning (IPC) in which the application of
brief cycles of non-lethal ischemia and reperfusion to the heart
reduced subsequent myocardial infarct size in the canine heart.
The drawback of this therapeutic strategy is the requirement
for the intervention to be applied prior to the index ischemic
event, which in the case of an acute myocardial infarction (MI)
is impossible to predict. However, the introduction of ischemic
postconditioning in 2003 (Zhao et al., 2003), a phenomenon in
whichtheprocessof myocardialreperfusionisinterruptedbysev-
eralshort-livedepisodesof ischemia,overcomesthisproblem,and
can be applied at the onset of myocardial reperfusion in patients
presenting with an acute MI. However, both IPC and ischemic
postconditioningrequireaninterventiontobeappliedtotheheart
directly which may not be feasible in all clinical settings. In this
regard, remote ischemic conditioning (RIC) may provide a non-
invasive endogenous therapeutic strategy for protecting the heart
against acute IRI.
Remote ischemic conditioning describes the cardioprotective
effect elicited from applying one or cycles of non-lethal ischemia-
reperfusion to an organ or tissue remote from the heart. It was
originally described by Przyklenk et al. (1993),who demonstrated
that the application of brief occlusions and reperfusion of the cir-
cumﬂex coronary artery dramatically reduced the size of the MI
arising from a sustained occlusion of the left anterior descending
coronary artery. This form of intramyocardial cardioprotection
across coronary territories was then extended beyond the heart
such that the latter could be protected by applying the RIC stim-
ulus to organs and tissues remote from the heart (Kanoria et al.,
2007; Hausenloy and Yellon, 2008; Tapuria et al., 2008; Candilio
et al., 2011). Furthermore, experimental studies found that it was
possible to protect non-cardiac organs and tissues from acute IRI.
AssuchRICrepresentsaformof systemicprotectionagainstacute
IRI, which has been recently translated into the clinical setting,
with the discovery that the RIC stimulus could be non-invasively
induced using a standard blood pressure cuff placed on the upper
a r mo rl e g( Kharbanda et al., 2002). Crucially, the timing of the
RIC stimulus can accommodate most clinical settings of acute
IRI, as it has been reported to protect the organ or tissue whether
applied prior to (termed remote ischemic preconditioning,RIPC;
Przyklenk et al.,1993),after the onset of ischemia (termed remote
ischemic perconditioning; Schmidt et al., 2007), or even at the
time of reperfusion (termed remote ischemic postconditioning,
RIPost;Kerendietal.,2005;Figure1).Thisreviewarticleprovides
an overview of RIC as a protective phenomenon, the underlying
mechanisms and its recent translation into the clinical arena.
APPLYING THE REMOTE ISCHEMIC CONDITIONING
STIMULUS
The original experimental study describing RIC demonstrated
intramyocardial cardioprotection across different coronary artery
territories (Przyklenk et al., 1993). However, soon after this dis-
covery it was demonstrated that the heart could be protected by a
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FIGURE 1 |The timing and the potential mechanisms underlying
remote ischemic conditioning (RIC).The RIC stimulus can be applied
prior to ischemia (preconditioning), after the onset of ischemia
(perconditioning), or at the time of reperfusion (postconditioning). A variety
of intracellular signaling mediators have been implicated in the protective
effect of RIC.Three main mechanisms for transmitting the protective signal
from the organ or tissue, in which the RIC stimulus is applied, to the target
organ or tissue (these are not mutually exclusive): (1) neural pathway, (2)
the release of circulating humoral factor(s), and (3) activation of a systemic
protective effect (such as an anti-apoptotic or anti-inﬂammatory response).
RIC stimulus applied to an organ remote from the heart such as
the kidney (McClanahan et al.,1993).
KIDNEY
McClanahan et al. (1993) demonstrated for the ﬁrst time that
a brief period of renal ischemia and reperfusion induced by
renal artery occlusion and reﬂow signiﬁcantly reduced myocar-
dial infarct size in the rabbit. It is of interest that Gho et al.
(1996) subsequently showed that 15min of renal artery occlu-
sion followed by 10min of reperfusion reduced myocardial IRI in
rats under hypothermic conditions but not normothermic condi-
tions. Similar ﬁndings were also demonstrated in a pig model of
acute myocardial IRI by the same research group (Verdouw et al.,
1996). These ﬁndings suggest that remote renal precondition-
ing may be temperature-sensitive, an observation that warrants
further investigation. Subsequent mechanistic studies have impli-
cated the involvement of adenosine (Pell et al., 1998; Takaoka
et al., 1999), ATP-sensitive potassium channels (KATP) channels
(Pell et al., 1998; Diwan et al., 2008b), angiotensin A1 receptors
(Singh and Chopra, 2004), erythropoietin (Diwan et al., 2008b),
NFκB( Diwan et al., 2008b; Kant et al., 2008), hypoxia-inducible
factor (Kant et al.,2008),PPARα and γ (Lotz et al.,2011)i nm e d i -





a ﬁnding which was conﬁrmed in a recent study (Tapuria et al.,
2008).UnlikeRICinducedbybrief renalischemia,theexperimen-
talstudyperformedbyVerdouwetal.(1996)foundthat15minof
mesenteric ischemia followed by 10min of reperfusion protected
the pig heart from subsequent IRI under both normothermic and
hypothermic conditions. Heidbreder et al. (2008) linked the car-
dioprotective effect of remote intestinal preconditioning to the
activation of p38 MAPK, ERK1/2, and JNK1/2 within the intesti-
nal tissue but not the heart. This result may suggest the activation
of local, but not the target organ, MAPK proteins to be an essen-
tial event for remote intestinal preconditioning (Heidbreder et al.,
2008). Pro-survival kinase activation within the heart in response
to remote organ preconditioning has been reported in several
recent studies (see Mechanisms Underlying RIC).
LIVER
A few experimental studies have investigated the liver as a site for
applyingaRICstimulus.Atesetal.(2002)ﬁrstshowedthat10min
of hepatic ischemia followed by 10min of reperfusion could ren-
der the kidney resistant to subsequent IRI. Similarly,RIC induced
by occlusion and reﬂow of the common hepatic artery and portal
veinwasdemonstratedtoattenuategastricmucosallesioninduced
by prolonged IRI, a protective effect which appeared to be medi-
ated by the cyclooxygenase pathway and the activation of sensory
afferent nerves (Brzozowski et al., 2004a). In addition to sensory
nerves, Brzozowski et al. (2004b) also demonstrated that the pro-
tectioninducedbyRICof liverwasattenuatedinvagotomizedrats
suggesting an important role of vagal nerves in the brain–gut axis.
Moreover,thegastroprotectionaffordedbyRICof liverwasshown
tobecomparabletothoseinducedbyRICof themyocardiumand
the direct stomach IPC (Brzozowski et al.,2004a,b).
BRAIN
As a vital organ that is susceptible to ischemic injury, the brain is
not the most suitable choice as a site for applying a RIC stimulus.
Anearlyporcinestudyshowedthat10or30minof brainischemia
with reperfusion, induced by elevating the intracranial pressure,
did not protect the heart from subsequent acute myocardial IRI
(deZeeuwetal.,2001).Onthecontrary,Valen’sgroupshowedthat
sustained brain ischemia (without reperfusion) induced by bilat-
eralinternalcarotidpermanentligationeffectivelyreducedMIand
improved cardiac function in mice (Tokuno et al., 2002; Schulte
et al., 2004). Although the reason for this discrepancy remains
unclear,thedifferencesinanimalspecies,degreeof ischemicstim-
ulus, and type of brain ischemia may explain these contradictory
results. It is interesting that this is one of the ﬁrst experimen-
tal studies to demonstrate protection elicited with an episode of
ischemia alone in the absence of reperfusion.
LIMB
The above experimental studies were dependent on the RIC stim-
ulusbeinginvasivelyappliedtoanon-cardiacorgan.However,the
clinical application of RIC would require a less invasive method
for applying the RIC stimulus. In this regard, Birnbaum et al.
(1997) made the critical observation that brieﬂy restricting blood
ﬂow to skeletal muscle of the lower limb and pacing the gastroc-
nemius leg muscle prior to an acute coronary artery occlusion
was able to reduce the subsequent myocardial infarct size by 65%
in the rabbit heart. A less invasive method of inducing hindlimb
ischemia as a RIC stimulus was described by Oxman et al. (1997)
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who demonstrated that applying a tourniquet to the hindlimb to
induce 10min of limb ischemia reduced reperfusion arrhythmias
in a rat heart following a sustained ischemic insult. Since then, a
number of experimental studies have conﬁrmed the use of lower
limb as a site for applying an RIC stimulus given it ease of access
and the fact that it can be applied using a simple tourniquet. In
general, limb RIC can be achieved by either tourniquet applica-
tion to the limb or direct occlusion of the femoral artery, and has
been shown to be effective and reproducible in reducing injury of
otherorganinbothanimalsandhuman(Tapuriaetal.,2008).The
ability to induce RIC using limb ischemia and reperfusion facili-
tated the translation of RIC into the clinical setting (see Clinical
Application).
THE TARGETS OF REMOTE ISCHEMIC CONDITIONING
HEART
The cytoprotective phenomenon of RIC was ﬁrst described in the
heart by Przyklenk et al. (1993) and has since been extended
to other organs and tissues (Kanoria et al., 2007; Hausenloy
and Yellon, 2008; Tapuria et al., 2008). The cardioprotective end
points conferred by RIC include infarct size reduction, improve-
ment of ATP recovery post-ischemia (Takaoka et al., 1999), anti-
arrhythmia (Oxman et al.,1997),and improvement of ventricular
contractile function (Kharbanda et al., 2002). The mechanisms
underlying the cardioprotective effect of RIC involve multiple
intricateendogenoussignalingpathways(seeMechanismsUnder-
lying RIC for detail). In brief, pre-clinical studies have provided
ﬁrst evidence to implicate the activation of adenosine (Pell et al.,
1998),bradykinin-2(SchoemakerandvanHeijningen,2000),opi-
oid (Patel et al., 2002), angiotensin-1 (Singh and Chopra, 2004),
and CB2 endocannabinoid (Hajrasouliha et al., 2008)r e c e p t o r s ,
openingofKATP channels(Pelletal.,1998),calcitoningene-related
peptide(CGRP;Tangetal.,1999),signalingreactiveoxygenspecies
(Weinbrenner et al., 2004), noradrenaline (Oxman et al., 1997),
nitric oxide (Wang et al., 2001), and heat shock proteins (HSPs;
Tanaka et al.,1998).
BRAIN
Stroke as a result of cerebral ischemia or intracranial hemorrhage
is the second leading cause of mortality and disability worldwide.
An elegant study by Jensen et al. (2011) found that RIPC of the
limb reduced brain edema, hemorrhage, and neuronal damage
caused by hypothermic circulatory arrest in pig, and these ben-
eﬁcial effects were associated with signiﬁcant improvement of
neurological function. In a rat model of focal cerebral ischemia,
neuroprotection was also evident in animals subjected to either
RIPC (Ren et al., 2008) or RIPost (Ren et al., 2009) of the limb.
KIDNEY
AcutekidneyinjuryduetoacuteIRIisafrequentcauseof morbid-
ity and mortality following a number of medical conditions and
operative procedures. Renoprotection by RIC was ﬁrst demon-
strated by Ates et al. (2002) who showed that brief liver ischemia
signiﬁcantly reduced the biochemical (TNFα and tissue thiobar-
bituricacid-reactivesubstances)andhistopathologicalmarkersof
renal ischemic injury. Similar renoprotection was reported using
limb ischemia,induced by brief infrarenal artery occlusion,as the
RIC stimulus (Lazaris et al., 2009). This is in agreement with a
recent study which reported renoprotection by remote limb pre-
conditioning via an adenosine-independent mechanism (Wever
et al., 2011). Interestingly, the author also showed that bilateral
RIPC was more effective than unilateral RIPC in reducing kidney
injury suggesting that the threshold of protection may be deter-
mined by the volume/mass of conditioned tissue (Wever et al.,
2011).
LIVER AND PANCREAS
Remote ischemic conditioning also has the potential to protect
the liver from IRI. In animal model of hepatic IRI, limb RIC has
been shown to reduce liver injury by improving hepatic blood
ﬂow, reducing serum aminotransferase levels, maintaining mean
arterial pressure,and reducing neutrophil adhesion and cell death
(Kanoriaetal.,2006;Tapuriaetal.,2009).Subsequentmechanistic
studies have implicated heme oxygenase-1 (HO-1; Lai et al.,2006;
Tapuria et al., 2009), nitric oxide (Abu-Amara et al., 2011a), and
eNOS(Abu-Amaraetal.,2011b)asthepotentialmediatorsofRIC-
induced liver protection. Peralta et al. (2001) have demonstrated
that brief hepatic ischemia resulted in less neutrophil inﬁltration,
less oxidative damage, and reduced vascular leakage in the pan-
creasfollowinghepaticIRI,possiblybysuppressingsystemicTNFα
release from the liver, and thus preventing adhesion molecule
P-selectin upregulation. This ﬁnding may suggest a therapeutic
potential of RIC in pancreatic diseases such as pancreatitis.
LUNG
During coronary artery bypass graft surgery the lung is subjected
to acute IRI, a scenario which can be reproduced experimentally
by repeated coronary artery occlusion and reperfusion to induce
pulmonary IRI. Using this experimental model, Xia et al. (2003)
showed that RIC of the limb preserved lung function in sheep.
Furthermore, RIC also reduced lung damage following liver IRI
(Peralta et al., 2001) or liver transplantation (Fernandez et al.,
2002). More recently, RIPC through intermittent limb ischemia
has also been reported to mitigate lung injury (inﬂammation,
oxidativestress,leukocyteinﬁltration,edema)resultingfromhem-
orrhagic shock and resuscitation via a HO-1 dependent manner
(Janetal.,2011).Inadditiontothesesecondarylunginjuries,RIC
can also protect lung from direct IRI as determined by improved
lung function and oxygenation capacity, and reduced pulmonary
hypertension (Waldow et al.,2005).
GASTROINTESTINAL TRACT
Remote ischemic conditioning induced gastroprotection was ﬁrst
illustrated by Brzozowski et al. (2004a) using a rat model of gas-
tric IRI. The authors showed that RIC applied to the heart or
liver signiﬁcantly reduced gastric mucosal lesions, improved gas-
tric blood ﬂow, increased mucosal prostaglandin E2 production,
and suppressed plasma proinﬂammatory cytokines (IL-1β and
TNFα)l e v e l s( Brzozowski et al., 2004a,b). Furthermore, Dickson
etal.(2002)havedemonstratedthatcoronaryefﬂuentof ischemic
preconditioned rabbit hearts contained humoral factor(s) that
improved jejunum resistance to ischemic injury through the acti-
vation of opioid receptors and opening of KATP channels. Others
have shown that RIC also reduced intestinal injury resulting from
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hepatic IRI (Peralta et al., 2001) and anastomotic insufﬁciency
(Holzner et al., 2011).
SKELETAL MUSCLE AND SKIN FLAP
Severalexperimentalstudieshavedemonstratedthecytoprotective
effect of RIC on muscle ﬂaps. Pre-clinical studies have illustrated
a protective effect of RIC against tissue necrosis of epigastric
adipocutaneousﬂaps(Kuntscheretal.,2003a,b)andskeletalmus-
cles such as cremaster (Kuntscher et al., 2002, 2003b; Wang et al.,
2004), gastrocnemius (Eberlin et al., 2009), latissimus dorsi, gra-
cilis, and rectus abdominis muscle ﬂaps (Addison et al., 2003;
Mosesetal.,2005).Theprotectionwasdemonstratedtobeassoci-
ated with improved microcirculation and endothelium function,
reducedleukocyteadhesionandaccumulation,andpreservedATP
content (Addison et al., 2003; Kuntscher et al., 2003b;Wang et al.,
2004).
MECHANISMS UNDERLYING RIC
A better understanding of the cellular and molecular mecha-
nisms underlying RIC may allow us to exploit the protective
effect pharmacologically. In general, the mechanisms underlying
the phenomenon of RIC can be considered as three inter-related
events (Kanoria et al., 2007; Hausenloy and Yellon, 2008; Tapuria
et al., 2008): (1) the initial events occurring in the remote organ
or tissue in response to the RIC stimulus. The application of brief
episodes of IR to the remote organ or tissue is believed to gen-
erate endogenous autocoids or factors which can protect target
organ or tissue from injury. (2) The protective signal which is
conveyed from the remote organ or tissue to the target organ or
tissue. The transmission of the protective signal may be multi-
factoralcomprisingblood-bornefactor(s),neuronalmechanisms,
and/or systemic responses. (3) The events occurring in the target
organ or tissue which confer the protective effect.
The intracellular signaling pathways recruited in the organ or
tissue in which the RIC stimulus is applied and the target organ
or tissue which has been protected are presumed to be similar
to those recruited in direct IPC and ischemic postconditioning.
There are a number of different signaling mediators including
G-protein cell surface coupled receptors (adenosine, bradykinin,
opioids, angiotensin), PKC, reactive oxygen species, nitric oxide,
Akt,Erk1/2,p38 MAPK,and STAT5 (Hausenloy andYellon,2008;
Heusch et al., 2012; Figure 1).
NEURONAL PATHWAY
Several experimental studies have implicated a neuronal path-
way as mediating the connection between the remote conditioned
organ or tissue to the protected organ and tissue (Hausenloy and
Yellon, 2008). Evidence for the involvement of the autonomic
nervous system are derived from studies using ganglion blockers
[hexamethonium (Gho et al.,1996;Schoemaker and van Heijnin-
gen,2000;Liemetal.,2002;Wolfrumetal.,2002)andtrimetaphan
(Loukogeorgakis et al., 2005)] to inhibit the protective effect of
RIC. Others have implicated the neuronal pathway by demon-
strating the loss of RIC protection in animals subjected to nerve
resection(Dingetal.,2001;Dongetal.,2004;Limetal.,2010)and
vagotomy (Brzozowski et al., 2004b). We have recently reported
that in the murine model of remote limb preconditioning the
neural pathway can be divided into separate components served
by the femoral and the sciatic nerves, as resection of either of
thesenervesaloneonlypartiallyblockedtheprotection(Limetal.,
2010).
The current understanding of the neuronal pathway involves
thereleaseofendogenousautocoids,includingneuropeptidessuch
as CGRP (Tang et al., 1999; Xiao et al., 2001; Brzozowski et al.,
2004a),adenosine (Ding et al.,2001;Liem et al.,2002;Dong et al.,
2004), and bradykinin (Schoemaker and van Heijningen, 2000),
from the remotely conditioned organ or tissue to activate local
afferentnerveswhichthenstimulateefferentnervesthatterminate
at the remote organ and tissue to mediate protection. Numerous
studies have further implicated sensory C-ﬁbers as the essential
ﬁrst leg of neurotransmission since RIC-induced protection can
be abrogated when subjects were pre-treated with capsaicin to
deactivatetheafferentsensorynerves(Tangetal.,1999;Xiaoetal.,
2001; Brzozowski et al.,2004a).
HUMORAL PATHWAY
A blood-borne factor conveying the cardioprotective signal from
the remote organ or tissue has been supported by two main
observations: (1) coronary efﬂuent from the ischemic condi-
tioned heart (Dickson et al., 1999a, 2001) or blood from the
conditioned animal (Dickson et al., 1999b) can protect a naive
recipient heart from IRI, suggesting the transfer of protective
humoral factor(s); and (2) a period of reperfusion of the remote
conditionedorganwasrequiredforprotectionsuggestingthatpro-
tective stimulus required wash-out of a protective blood-borne
humoral factor(s) generated in the conditioned site and trans-
ported throughout the circulation (McClanahan et al., 1993; Gho
et al.,1996;Weinbrenner et al., 2002).
Activation of adenosine (Pell et al., 1998; Takaoka et al., 1999;
Kerendi et al., 2005; Tsubota et al., 2010), bradykinin-2 (Wol-
frum et al., 2002), opioids (Dickson et al., 2001, 2002; Patel et al.,
2002; Weinbrenner et al., 2004; Zhou et al., 2011), erythropoietin
(Diwanetal.,2008a,b),CB2 endocannabinoid(Hajrasoulihaetal.,
2008),angiotensin-1(SinghandChopra,2004),andprostaglandin
(Brzozowski et al., 2004a) receptors and the associated signaling
pathways has been implicated in mediating the protective effect of
RIC.However,whethertheyconstitutetheendogenoussubstances
that are generated in the remote conditioned organ or tissue
and being transported to the injured organ target through blood
circulation remains unknown.Although the actual identity of cir-
culating humoral factors remains unknown, an elegant study by
Shimizu et al. (2009) has identiﬁed the cardioprotective humoral
factors, generated in response to RIPC of limb, to be hydropho-
bic and <15kDa in size. Serejo et al. (2007) showed that the
humoral factors released from the ischemic preconditioned heart
were thermolabile,hydrophobic,and >3.5kDa,which cardiopro-
tect via PKC activation. Similarly, Breivik et al. (2011) reported
that coronary IPC efﬂuent contained hydrophobic cytoprotective
factors with molecular mass of <30kDa,which conferred cardio-
protection via PI3K/Akt pathway when administered either as a
preconditioningorpostconditioningmimetic.Anearlyproteomic
study of renal RIC in rats did not detect any supported protective
factors with molecular mass of >8kDa (Lang et al., 2006). Taken
together, the humoral factors are likely to be hydrophobic with a
Frontiers in Physiology | Clinical andTranslational Physiology February 2012 | Volume 3 | Article 27 | 4Lim and Hausenloy Remote ischemic conditioning
molecular mass between 3.5 and 8kDa. Why the identiﬁcation of
the humoral factor(s) continues to elude investigators thus far is
unclear.
SYSTEMIC RESPONSE
Remote ischemic conditioning has been shown to provoke a
systemic protective response involving modulation of immune
cells either at post-translational level or through transcriptional
regulation (Saxena et al., 2010). Microarray analysis of blood
samples obtained from healthy human volunteers subjected to
brief forearm ischemia revealed suppression of proinﬂamma-
tory genes encoding proteins involve in leukocyte chemotaxis,
adhesion, migration, and exocytosis, as well as innate immu-
nity responses, cytokine synthesis, and apoptosis. On the other
hand, anti-inﬂammatory genes such HSP 70 and calpastatin were
upregulated (Konstantinov et al., 2004). The changes of this gene
expressionproﬁlewerelaterfoundtobecorrelatedwithfunctional
changes in human leukocytes, an effect last up to 10days after
RIPC (Shimizu et al., 2010). This ﬁnding was in agreement with
a previous study reported that RIPC of forearm reduced expres-
sion of neutrophil CD11b and platelet–neutrophil complexes in
human volunteers (Kharbanda et al., 2001). IPC of liver has also
been shown to attenuate increased in P-selectin expression and
neutrophil inﬁltration in multiple remote organs (including lung,
stomach,pancreas,small intestine,and colon) through inhibition
of systemic TNFα production (Peralta et al., 2001). Subsequent
studies in mice also showed upregulation of genes associated
with cytoprotection, growth and metabolism, DNA repair, and
redox regulation by RIPC of the limb (Konstantinov et al.,2005a)
and mesenteric (Huda et al., 2005). Furthermore, Li et al. (2004)
demonstrated that delayed RIPC-induced cardioprotection was
abrogated in mice with deﬁcient in transcription factor NFκB
p105 subunit supporting the important role of gene transcription
in mediating the protective effect of RIC.
NOVEL CONCEPTS IN REMOTE ISCHEMIC CONDITIONING
DELAYED REMOTE ISCHEMIC PRECONDITIONING
Similar to IPC,there are two phases of RIPC:early RIPC results in
acute protection through post-translational protein modiﬁcation,
anddelayedRIPCprovidingsecondphaseofprolongedprotection
against ischemic injury (Table 1). An elegant temporal charac-
teristic study by Moses et al. (2005) has demonstrated that the
therapeutic time window of delayed RIPC is similar to conven-
tional IPC, i.e., from 24h and lasting for up to 72h. Interestingly,
a recent study in rat focal cerebral ischemia has shown that the
delayed protection of RIPC can be initiated as early as 12h after
stimulus, narrowing the gap between the early and delayed pro-
tection (Ren et al., 2008). Several studies have implicated iNOS
as one of the mechanism underlying the delayed RIPC (Wang
et al., 2001; Xiao et al., 2001; Tokuno et al., 2002; Li et al., 2004).
Other potential mechanisms include α-CGRP (Tang et al., 1999;
Xiao et al., 2001; Hu et al., 2002), sarcolemmal KATP channels
(Moses et al., 2005), mitochondria KATP channels (Moses et al.,
2005; Wu et al., 2011), and antioxidant MnSOD (Yuan et al.,
2010; Wu et al., 2011). Using a knock-out model, Schulte et al.
(2004) have shown that adenosine A1 receptor is essential for the
delayed cardioprotection induced by permanent bilateral ligation
of the internal carotid arteries. However, this delayed protection
may not be considered as a“true”preconditioning because it was
not produced by the conventional protocol of brief ischemia and
reperfusion.
DELAYED REMOTE ISCHEMIC POSTCONDITIONING
Previous studies have suggested that reperfusion-induced inﬂam-
matory responses occur not only at the early phase of reperfusion,
but also extend to prolonged reperfusion (Boyle et al.,1997). Sim-
ilarly, Zhao et al. (2000, 2001) have demonstrated a progressive
increase in the extent of myocardial injury from early (6h) to late
periods (24–48h) of reperfusion in canine hearts. These ﬁndings
suggest that myocardial reperfusion injury may be an ongoing
process resulting in a “wavefront of reperfusion injury” thereby
providing an extended window for therapeutic intervention. In
this regard,Ren et al. (2009) showed that,at least in the brain,the
infarct-sparing effect of RIPost was still evident when the appli-
cation of RIPost was delayed by 3h, but not 6h, into reperfusion.
WhetheritispossibletodelayRICinotherorgansortissueremains
to be determined.
Table 1 | Experimental studies on delayed remote ischemic preconditioning.
Species RIPC site Delayed duration (h) Site of ischemic insult Potential mechanisms Study
Mouse Hindlimb 24 Heart iNOS, NFκB Li et al. (2004)
Brain 24–32 iNOS Tokuno et al. (2002)
24 Adenosine A1 Schulte et al. (2004)
Rat Hindlimb 12 and 48 Brain – Ren et al. (2008)
24 MnSOD, xanthine oxidase Yuan et al. (2010)
24 Heart MnSOD, mKATP Wu et al. (2011)
24 Cremaster muscle – Kuntscher et al. (2003b)
Intestine 24 Heart iNOS Wang et al. (2001)
24–72 iNOS, CGRP Xiao et al. (2001)
24 CGRP Hu et al. (2002)
Rabbit Intestine 24 Heart CGRP Tang et al. (1999)
Pig Hindlimb 24–72 Latissimus dorsi muscle mKATP,s K ATP Moses et al. (2005)
Human Arm 24–48 Contralateral arm Autonomic nervous system Loukogeorgakis et al. (2005)
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CHRONIC STIMULUS FOR LONG-TERM PROTECTION
The majority of RIC studies have focused on administering a sin-
gle RIC stimulus and demonstrating acute protection against IRI
(Hausenloy and Yellon, 2008). Intriguingly, a recent experiment
study has demonstrated that administering repeated remote limb
postconditioning over 2weeks could prevent adverse LV remod-
eling in the rat heart following an acute MI (Wei et al., 2011).
The cardioprotection afforded by repeated RIC was shown to be
associated with reduced myocardial oxidative stress and inﬂam-
matory cell inﬁltration (Wei et al., 2011). This ﬁnding is in
agreement with the authors’ previous study conducted in healthy
human volunteers in which RIPC applied daily to the forearm for
10days negatively affected circulating neutrophil function includ-
ing reduction in adhesion,exocytosis,phagocytosis,and enhance-
ment in lipopolysaccharide-induced cytokine secretion (Shimizu
et al.,2010).
REMOTE PRECONDITIONING OF TRAUMA
Ren et al. (2004) showed that a single abdominal surgical incision
protected the murine heart from subsequent acute IRI in a TNFα-
independent manner. This study suggested that protection could
be elicited by non-ischemic stimulus which they term “remote
preconditioning of trauma.” A subsequent mechanistic study by
the same group has revealed the involvement of neurogenic path-
wayswherebytransverseabdominalincisionstimulatesperipheral
nociception which in turn activate the cardiac sympathetic nerves
via spinal nerves and induce cardioprotection through the activa-
tionof PKC-εandinhibitionof PKC-δinabradykinin-dependent
manner as well as the activation of the mitochondria KATP chan-
nels(Jonesetal.,2009).Furthermore,arecentstudybyGrossetal.
(2011) has conﬁrmed this protective phenomenon in a larger ani-
mal model (i.e., dog) and has implicated the cytochrome P450
epoxygenase pathway as a mediatory factor. Interesting, remote
preconditioning of trauma could be mimicked non-invasively by
topicalapplicationof capsaicintodirectlystimulatethecutaneous
sensory C-ﬁbers suggesting a novel clinical application of remote
conditioning without ischemia or trauma (Jones et al.,2009).
REMOTE ISCHEMIC CONDITIONING FOR ORGAN TRANSPLANT
In addition to protecting the host’s organs and tissues, RIC has
been shown to confer the ability to protect transplanted organs
from injury. In a porcine model of orthotopic heart transplanta-
tion, Konstantinov et al. (2005b) demonstrated that four 5min
cyclesof RIPCappliedontherecipient’slimbcanprotecttheden-
ervated donor heart from acute IRI. On the other hand, RIPC
applied on the donor’s limb signiﬁcantly reduced myocardial
injury in explanted donor heart subjected to ex vivo IRI on a
Langendorff preparation (Kristiansen et al., 2005). This ﬁnding
suggested that the protective information is remembered within
theexplantedheartwithouttheneedofongoingstimulation.Both
studies also showed that the protection conferred by RIPC was
abolished by glibenclamide suggesting a KATP channel-depending
mechanism (Konstantinov et al., 2005b; Kristiansen et al., 2005).
Using speciﬁc blockers of KATP channels given before myocar-
dial IRI and after the heart had been explanted, Kristiansen et al.
(2005) further identiﬁed activation of mitochondrial KATP, but
not sarcolemmal KATP, channel as the main end effector of RIPC
in the protected organ. These early studies have indicated RIC as
a potential protective strategy for future organ transplantation in
human.
MOBILIZATION OF ENDOGENOUS STEM AND PROGENITOR CELLS
Recent advances in cell biology have identiﬁed endogenous stem
and progenitor cells as part of innate reparatory components after
organ or tissue injury. Endogenous stem and progenitor cells can
be mobilized to target tissues and serve as integrated participants
in regenerating the injured organ or tissues and/or as supportive
playersviapleiotropicparacrineeffects(Chenetal.,2011;Krankel
et al., 2011). An early study by Ii et al. (2005) demonstrated the
ability of IPC to recruit endogenous endothelial progenitor cells
to the infarcted myocardium in a NOS-dependent manner and
this effect was associated with infarct size reduction, increased
angiogenesis, and improvement of cardiac function. The mobi-
lizing and homing effect of IPC was subsequently illustrated on
other cell types including mesenchymal and hematopoietic stem
cells in a porcine model of acute myocardial IRI (Gyongyosi et al.,
2010). In the setting of RIPC, Kamota et al. (2009) showed that
intermittent abdominal aorta occlusion increased the accumu-
lation of bone marrow-derived sca-1+ and c-kit+ stem cells in
infarcted hearts through a SDF-1/CXCR4-dependent mechanism.
These encouraging ﬁndings may have a positive impact on future
clinical translation of RIC.
CLINICAL APPLICATION
The ability to recapitulate RIC protection using the upper or
lower limb has greatly facilitated the translation of RIC into the
clinicalsettingof acuteIRI.PreliminaryclinicalstudiesbyMacAl-
lister’s group (Kharbanda et al.,2002) ﬁrst demonstrated that RIC
could be non-invasively reproduced in human volunteers using a
standard blood pressure cuff to induce brief cycles of non-lethal
ischemiaandreperfusioninthearm.Sincethen,anumberof clin-
ical studies have investigated RIC in different clinical settings of
acute IRI.
PROTECTING THE HEART USING RIC
The majority of the clinical RIC studies have been designed to
investigate whether the heart can be protected against acute IRI
in a variety of clinical settings including cardiac surgery, dur-
ing percutaneous coronary intervention (PCI), and in an acute
MI. In 2006, the ﬁrst clinical proof-of-concept clinical study to
demonstrate that RIC may be beneﬁcial in the clinical setting was
conducted in children undergoing corrective cardiac surgery for
congenital heart disease (Cheung et al.,2006),an operation which
is normally associated with signiﬁcant morbidity and mortality
due to inadequate cardioprotection during surgery. In that study,
Cheung et al. (2006) reported that RIC (four 5min cuff inﬂations
anddeﬂationsof acuff placedonthethighto15mmHgabovesys-
tolicbloodpressure)administeredpriortocardiacsurgeryreduced
peri-operative myocardial injury (less troponin I release),lowered
inotrope requirements and reduced airway pressures. A year later,
we demonstrated that (three 5min cuff inﬂations and deﬂations
of a cuff placed on the upper arm to 200mmHg) administered
prior to cardiac surgery reduced peri-operative myocardial injury
(43%lesstroponinTrelease)inadultpatientsundergoingelective
CABG surgery (Hausenloy et al., 2007).
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Since the publication of these clinical studies there have been
both positive (Venugopal et al., 2009; Li et al., 2010; Thielmann
et al., 2010; Choi et al., 2011) and negative (Rahman et al., 2010;
Karuppasamy et al., 2011) studies with RIC in this clinical set-
ting. The reasons for these divergent ﬁndings are not clear but
may be attributable to a number of different factors including:
(1) the use of concomitant medication such as inhaled anes-
thetics (for example isoﬂurane), intravenous anesthetics such as
propofol, and intravenous nitrates all of which may cardiopro-
tect during CABG surgery; (2) the timing of the RIC stimulus
which was prior to cardiac surgery in the positive studies and
was after surgical incision in one of the negative studies (Rah-
man et al., 2010); (3) the patient population and type of cardiac
surgery. Whether RIC is actually beneﬁcial in the clinical setting
of CABG surgery should become clearer with the completion of
two large multi-center randomized controlled clinical trials in the
UK (the ERICCA trial; Hausenloy et al., 2011) and Germany (the
RIPHeart trial; http://clinicaltrials.gov/ct2/show/NCT01067703).
RIC has also been reported to protect the heart in a number of
different clinical settings of acute IRI including abdominal aor-
tic aneurysm surgery (Ali et al., 2007), elective PCI (Hoole et al.,
2009),and ST-elevation MI (Botker et al.,2010;Munk et al.,2010;
Rentoukasetal.,2010).However,furtherstudyisrequiredtochar-
acterize the most effective RIC stimulus in these different clinical
settings.
PROTECTING OTHER ORGANS AND TISSUE USING RIC
Remote ischemic conditioning using the upper to lower limb
has the potential to be beneﬁcial in other organs and tissue
such as the kidney, brain, liver, lung, and so on. Acute kidney
injury following CABG or major vascular surgery is associated
with worse clinical outcomes. Preliminary clinical studies have
reported beneﬁcial effects of RIC in these settings in terms of
reduced incidence of acute kidney injury (Ali et al., 2007; Venu-
gopal et al., 2010), although not all studies have been positive
(Rahman et al., 2010; Choi et al., 2011). Recent clinical stud-
ies have implicated remote limb preconditioning to be safe and
well tolerated in patients with aneurysmal subarachnoid hem-
orrhage (Koch et al., 2011) and carotid endarterectomy (Walsh
et al., 2010), supporting the aforementioned encouraging ani-
mal data and future clinical trials. The REPAIR trial is currently
investigating whether RIC can improve graft renal function in
patientsundergoinglivedonor-relatedrenaltransplantation.Clin-
ical studies are required to investigate whether RIC can protect
the brain, liver, and other organs against acute IRI. Successful
results from experimental studies raise the possibility of apply-
ing RIC in elective reconstructive and ﬂap microsurgery such
as adipose tissue grafting to the post-mastectomy patient, autol-
ogous muscle transplantation for wound coverage, skin graft-




egy for the prevention of acute IRI in susceptible organs and
tissues. The ability to induce RIC using a standard blood pressure
cuff placed on the upper or lower limb has facilitated its transla-
tion into the clinical setting. RIC is simple to apply, non-invasive
and virtually cost-free, and a single RIC stimulus offers multi-
organ protection, lending itself to a variety of clinical settings in
which there is organ or tissue acute IRI. The promising results
obtainedfromseveralproof-of-conceptclinicalstudies(mainlyin
the heart) have encouraged further laboratory investigation into
the complex mechanisms underlying its protective effect. A better
understanding of the complex signaling events involved in trans-
duction of the RIC signal from the remote organ and tissue to
the protected target may allow the imminent discovery of novel
pharmacologicalagentstodirectlyactivatetheprotectivesignaling
pathways. For now large multi-center clinical trials are underway
toinvestigatewhetherRICcanactually improve clinical outcomes
in patients with CHD.
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